Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The TCM segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment consists of agency products and internally manufactured products which are marketed through the distribution arm. The company was founded on September 29, 2003 and is headquartered in Chengdu, China.